Immunogenic cell death inducers as anticancer agents

Oncotarget

Volumn 5, Issue 14, 2014, Pages 5190-5191

  Kepp, Oliver ^a   Senovilla, Laura ^a   Kroemer, Guido ^a  

^a CENTRE DE RECHERCHE DES CORDELIERS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CALRETICULIN;

CANCER CELL LINE; CANCER CHEMOTHERAPY; CANCER IMMUNOLOGY; CELL DEATH; DRUG APPROVAL; DRUG EFFICACY; DRUG SCREENING; EDITORIAL; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENCE; IMMUNOGENICITY; NONHUMAN; ANIMAL; DRUG EFFECTS; IMMUNOLOGY; MOUSE; NEOPLASMS; PATHOLOGY;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL DEATH; HUMANS; MICE; NEOPLASMS;

EID: 84906255404     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.2266     Document Type: Editorial

References (8)

1. Zitvogel L et al. Immunity. 2013; 39(1):74-88.
2. Kroemer G et al. Annual review of immunology. 2013; 31:51-72.
3. Menger L et al. Science translational medicine. 2012; 4(143):143ra199.
4. Senovilla L et al. Science. 2012; 337(6102):1678-1684.
5. Menger L et al. Oncoimmunology. 2013; 2(2):e23082.
6. Sukkurwala AQ et al. Oncoimmunology. 2014; 3(3):e28473.
7. Kepp O et al. Oncoimmunology. 2013; 2(11):e27157.
8. Vacchelli E et al. Oncoimmunology. 2013; 2(3):e23510.